Trump directs HHS, FDA to require full safety warnings in drug ads

President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies to include full safety warnings on their consumer advertisements. HHS and the FDA announced they will remove a loophole from a 1997 provision that allowed drug advertisers to display safety information in a different format or location. Additionally, HHS said the FDA would begin aggressive enforcement of direct-to-consumer violations.